AI Summary
5 min readA middle-aged woman named Mary had been struggling with alcohol addiction for decades. She could drink 18 beers in a sitting, and treatments like Alcoholics Anonymous, Antabuse, and rehab had all failed. Then a friend on Ozempic told her she could barely bring herself to drink two beers anymore. Mary enrolled in a clinical trial where she was blindly injected with either semaglutide or a placebo. Within weeks, the "alcohol noise" in her head vanished. She stopped ruminating about where to drink, how much to drink, and how not to drink. She switched from beer to white wine, then stopped drinking entirely. She lost 55 pounds in five months, started exercising, and even ended a long-troubled marriage. She had to come off the medication because she lost weight too quickly, but her sobriety held.
Continue reading the full summary in the app — free to try.
Read Full Summary →Free • No credit card required
Never miss an episode of TED Radio Hour
Get every new episode summarized in your inbox — free, ~5 minutes to read.
No spam. Unsubscribe anytime.
What you'll learn
- 1 (00:19) **Show Introduction** - Host Manoush Zomorodi introduces the theme of addiction and moderation.
- 2 (01:18) **Dr. Drew Collard Introduces the Problem of Excess** - Physician at Weill Cornell Medical College discusses how the modern world is designed for "too much," making moderation difficult for some.
- 3 (01:58) **Patient Case: Mary's Struggle with Alcohol** - A middle-aged woman with a decades-long alcohol addiction fails to find relief through AA, Antabuse, and rehab.
- 4 (02:34) **Mary's Discovery of Ozempic** - A friend on Ozempic loses interest in drinking, prompting Mary to join a clinical trial for semaglutide and alcohol addiction.
- 5 (03:26) **Mary's Transformation on the Drug** - Within weeks, Mary loses all desire for alcohol, describing it as "alcohol noise" vanishing. She makes major life changes, including ending a troubled marriage and losing 55 pounds.
- 6 (04:59) **The Promise of GLP-1s for Addiction** - Dr. Collard explains that nearly one in six Americans has a substance use disorder, and GLP-1s offer a potential new era in treatment, over 20 years since the last FDA-approved alcohol use disorder medication.
- 7 (06:35) **The "Moderation Molecule" Theory** - GLP-1s might limit dopamine spikes in the brain's reward system, calming cravings without extinguishing all desire, suggesting a "universal pathology" for addiction.
+ Full timestamped outline available in the app
Show Notes
See pcm.adswizz.com for information about our collection and use of personal data for sponsorship and to manage your podcast sponsorship preferences.
NPR Privacy Policy
More from this podcast
TED Radio Hour →